Capstone Therapeutics Corp. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced operating loss was USD 605,000 compared to operating Income of USD 1.340 million a year ago. Net loss was USD 668,000 compared to net income of USD 1.278 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to basic earnings per share from continuing operations of USD 0.02 a year ago. For the half year, operating loss was USD 1.394 million compared to operating Income of USD 810,000 a year ago. Net loss was USD 1.523 million compared to net income of USD 691,000 a year ago. Basic loss per share from continuing operations was USD 0.03 compared to basic earnings per share from continuing operations of USD 0.01 a year ago.